


Sneezing fits, a blocked nose, itchy eyes, and skin hives disturb sleep, work, and school. Allergies now affect people in every age group, and pollution makes the problem worse in many Indian cities. Bilastine 20mg + Montelukast Sodium 10mg is a fixed-dose combination that doctors prescribe for allergic conditions of the nose, airways, and skin. This guide explains how it works, where doctors use it, and which safety rules matter. It also shows why this product attracts distributors who want to join a PCD pharma franchise company in India.
This is a fixed-dose combination tablet with two active ingredients:
“I.P.” means the Montelukast meets Indian Pharmacopoeia standards. Doctors and chemists value this quality mark.
An allergic reaction releases several chemicals at once. Histamine causes quick symptoms such as itching and sneezing. Leukotrienes cause swelling, mucus, and blocked airways. One drug alone often leaves part of the problem untreated.
Bilastine blocks histamine receptors, so itching, sneezing, and runny nose settle. It causes little drowsiness because it barely crosses into the brain.
Montelukast blocks leukotriene receptors. Airway swelling, congestion, and mucus fall, and breathing improves.
Together, the two drugs control a wider range of allergy symptoms than either drug alone.
Doctors prescribe this combination for conditions such as:
The tablet relieves symptoms. It does not cure allergy, and it does not replace rescue inhalers in an asthma attack.
| Benefit | What It Means for the Patient |
| Dual action | Blocks both histamine and leukotriene pathways |
| Low sedation | Patients stay alert during the day |
| Once-daily dosing | One tablet simplifies the routine |
| Wide symptom control | Eases nose, eye, skin, and airway symptoms |
| Familiar molecules | Physicians and allergy specialists know both drugs well |
A doctor decides the right dose after checking the patient’s condition. In general:
Doctors review the dose for patients with severe kidney problems.
Honest safety messaging builds trust with doctors and patients.
This medicine needs a prescription. Self-medication carries real risk.
BILASTIC M | Ojana Pharmaceutical offers this combination to franchise partners. It enters the allergy and respiratory segment, an area with steady, year-round demand.
Why does this product suit distributors?
The Indian pharmaceutical industry keeps expanding, which creates room for new franchise partners. Industry sources report these trends:
Note: Market figures change every year. Verify the latest numbers on IBEF, the Department of Pharmaceuticals, or IQVIA before you publish.
A PCD pharma franchise company in India allows you to market branded medicines in your own territory. PCD means Propaganda Cum Distribution. You promote the company’s products, handle local sales, and build your own business identity.
This model suits medical representatives, chemists, distributors, and first-time entrepreneurs.
Buyers often search for the top 10 PCD pharma franchise companies in India before they commit. No official ranking exists, so judge each company on facts. Use this checklist:
A company that meets most of these points deserves a place on your shortlist.
In 2026, doctors continue to prescribe Bilastine 20mg + Montelukast Sodium I.P. 10mg for allergic rhinitis, chronic urticaria, and allergic symptoms linked to mild airway problems. It blocks both histamine and leukotriene pathways.
Patients should take Bilastine 20mg + Montelukast Sodium I.P. 10mg once daily on an empty stomach, as their doctor directs. Current 2026 guidance advises avoiding food and fruit juice close to the dose.
Yes. In 2026, Bilastine 20mg + Montelukast Sodium I.P. 10mg remains a prescription medicine in India. Chemists should dispense it only against a valid prescription.
Users in 2026 may notice headache, mild drowsiness, dry mouth, or stomach upset with Bilastine 20mg + Montelukast Sodium I.P. 10mg. Patients should report any mood or sleep change to a doctor at once.
Safety guidance in 2026 tells people with allergy to either ingredient to avoid Bilastine 20mg + Montelukast Sodium I.P. 10mg. Pregnant and breastfeeding women should consult a doctor first.
BILASTIC M | Ojana Pharmaceutical is a branded tablet that contains Bilastine 20mg + Montelukast Sodium I.P. 10mg. The company offers it to franchise partners who want an allergy and respiratory product in their range.
Demand for allergy and respiratory medicines stays strong in 2026 as pollution and urban living raise allergy cases and the Indian pharma market moves toward its USD 130 billion target for 2030. Bilastine 20mg + Montelukast Sodium I.P. 10mg gives a PCD pharma franchise company in India a reliable, repeat-prescription product.
Check licences, GMP certification, territory rights, and batch quality reports. In 2026, choose a company that supplies Bilastine 20mg + Montelukast Sodium I.P. 10mg with transparent terms and reliable delivery.
Bilastine 20mg + Montelukast Sodium I.P. 10mg offers dual-pathway relief for allergic rhinitis and urticaria with low sedation, and doctors prescribe it widely. For entrepreneurs, BILASTIC M | Ojana Pharmaceutical opens a strong path into the allergy and respiratory segment. Pick your franchise partner with care, verify every claim, and promote the product with honest, safe-use messaging.
Disclaimer: This article provides general information only. It does not replace professional medical advice. Always consult a qualified doctor before you use any medicine.